Usa Micro Invasive Glaucoma Surgery Migs Devices Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 537.32 Billion |
Market Size (Forecast Year) |
USD 5,519.27 Billion |
CAGR |
|
Major Markets Players |
美国微创青光眼手术 (MIGS) 设备市场,按产品(MIGS 支架、MIGS 分流器等)、目标(小梁网脉络膜上腔结膜下滤过和减少房水产生)、手术类型(合并白内障的青光眼和独立的青光眼)、最终用户(医院门诊部 (HOPD)、眼科诊所、门诊手术中心(ASCS) 等)、分销渠道(直接招标和零售销售)– 行业趋势和预测到 2030 年。
美国微创青光眼手术 (MIGS) 设备市场分析和规模
过去几年,微创青光眼手术 (MIGS) 已成为治疗青光眼的可行方案。阻止青光眼进展的唯一既定方法是降低眼压 (IOP)。从历史上看,非手术(如局部用药或激光治疗)和手术方法(小梁切除术或青光眼引流装置)都已用于实现这一目标。这些方法都不完美,因为手术并发症频繁发生,药物依从性是主要问题。在治疗轻度至中度原发性开角型青光眼患者时,MIGS 经常与白内障手术配合使用,因为它具有较高的安全性,这使得它比其他类型的青光眼手术 (POAG) 更早使用。
Data Bridge Market Research 分析,微创青光眼手术 (MIGS) 设备市场在 2022 年的规模为 5.3732 亿美元,预计到 2030 年将达到 55.1927 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 33.8%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
美国微创青光眼手术 (MIGS) 设备市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
产品(MIGS 支架、MIGS 分流器等)、目标(小梁网脉络膜上腔结膜下滤过和减少房水产生)、手术类型(合并白内障的青光眼和独立的青光眼)、最终用户(医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 等)、分销渠道(直接招标和零售) |
涵盖的市场参与者 |
Glaukos Corporation(美国)、Ivantis Inc.(美国)、AbbVie Inc.(美国)、Ellex(美国)、Alcon(瑞士)、BVI(美国)、Johnson and Johnson Surgical Vision Care Inc.(美国)、Microsurgical technology(美国)、Molteno Ophthalmic Ltd.(新西兰)、New world Medical Inc.(美国)、Santen Pharmaceutical Co., Ltd.(日本)、Sight Scientific(美国)、Bausch & Lomb Incorporated.(加拿大)、NeoMedix Healthcare India Pvt. Ltd.(美国)IOPtima(以色列) |
市场机会 |
|
市场定义
微创青光眼手术是青光眼治疗的一种形式 (MIGS)。它代表了轻度至中度青光眼治疗的重大进步。它提供了一种替代以前用药的方法,并消除了与传统手术相关的风险。这些方法希望通过降低眼压来避免损伤视神经。与标准手术相比,这些技术更安全,恢复时间也更短。
美国微创青光眼手术 (MIGS) 设备市场动态
驱动程序
- 眼科疾病发病率增加
人口老龄化和失明问题日益严重,推动了微创青光眼手术 (MIGS) 设备市场的发展。白内障和青光眼是老年人最常见的两种与年龄有关的眼部疾病,也是失明的主要原因。此外,由于设备技术进步和患者对微创手术的认识不断提高,对青光眼和白内障联合治疗的需求不断增加,推动了微创青光眼手术 (MIGS) 设备市场的增长。
- 全球青光眼发病率上升
眼科治疗市场的主要参与者正致力于制造微创青光眼手术 (MIGS) 支架,以实现更有效的治疗。因此,对 MIGS 设备(微创青光眼手术)的需求预计将增加。
- 技术先进产品介绍
青光眼是一种严重的眼部疾病,如果不及时治疗,会导致视力丧失。由于目前医学上可以治疗青光眼,而且有许多方法可以限制进一步的伤害,因此青光眼通常不会导致失明。随着科学的进步,青光眼的治疗方法发生了巨大变化。微创青光眼手术的引入,医学发生了范式变化,因为它可以帮助早期治疗青光眼,并消除对小梁切除术等过滤手术的依赖。此外,这消除了与这些切口手术相关的危险。MIGS 在青光眼治疗方面取得了许多进步。
机会
- 政府采取措施提高公众对预防失明的认识
WHO estimates that at least 2.2 billion individuals worldwide have some form of vision impairment or blindness, at least 1 billion of them have a condition that might have been avoided. The government of many nations throughout the world has taken action to stop this. This fuels the market for micro invasive glaucoma surgery (MIGS) devices and increases the demand for cutting-edge therapies such as micro-invasive glaucoma surgery. Consequently, it is anticipated to operate as a market driver.
Restraints/Challenges
- Stringent regulations for MIGS devices
In the United States, any device manufacturer must comply with at least seven regulations, including Establishment Registration and Medical Device Listing, Premarket Notification 510(k), Premarket Approval (PMA) (only for class three devices), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, Labeling requirements, and Medical Device Reporting (MDR). These high-risk devices require a more stringent premarket application regulatory process to demonstrate valid evidence of safety and efficacy. Long timelines result in delayed access, which may limit the market for micro invasive glaucoma surgery (MIGS) devices.
This micro invasive glaucoma surgery (MIGS) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the micro invasive glaucoma surgery (MIGS) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Micro Invasive Glaucoma Surgery (MIGS) Devices Market
The COVID-19 pandemic is a global public health emergency that is projected to have a detrimental impact on the market for micro invasive glaucoma surgery (MIGS) devices. Glaucoma specialists prefer the trabeculectomy procedure for glaucoma surgery. Prior to the COVID-19 epidemic, the iStent inject, followed by XEN and Preserflo was the most frequently done MIGS device procedure in minimally invasive glaucoma surgery (MIGS). Although trabeculectomy is still the most common established glaucoma operation due to the reduced number of postoperative visits and medications, it is being performed with less frequency during the COVID-19 epidemic.
Recent Development
- In 2022, Glaukos announced the first patient enrollment in GLK=301's Phase II clinical trial for dry eye disease. This drug will help the company grow its business segment if the regulatory body approves it.
- 2022 年,爱尔康收购了新型 Hydrus Microstent 的开发商 Ivantis,这是一种微创青光眼手术 (MIGS) 设备。该手术设备旨在降低开角型青光眼患者的眼压。此次收购将扩大该公司在眼科手术方面的产品组合。
美国微创青光眼手术 (MIGS) 设备市场范围
微创青光眼手术 (MIGS) 设备市场根据目标、产品、手术类型、分销渠道和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
目标
- 小梁网
- 脉络膜上腔
- 结膜下滤过
- 减少水性生产
- 其他的
产品
- MIGS 支架
- MIGS 分流器
- 其他(小梁切除术/微植入物/微导管)
手术类型
- 青光眼并发白内障
- 独立性青光眼
最终用户
- 医院门诊部(HOPD)
- 眼科诊所
- 门诊手术中心 (ASCS)
- 其他的
分销渠道
- 直接招标
- 零售销售
医疗保健基础设施增长安装基础和新技术渗透
微创青光眼手术 (MIGS) 设备市场还为您提供详细的市场分析,包括每个国家/地区资本设备医疗支出的增长、微创青光眼手术 (MIGS) 设备市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对微创青光眼手术 (MIGS) 设备市场的影响。数据适用于 2011-2021 年的历史时期。
竞争格局和微创青光眼手术 (MIGS) 设备市场份额分析
微创青光眼手术 (MIGS) 设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对微创青光眼手术 (MIGS) 设备市场的关注有关。
微创青光眼手术 (MIGS) 设备市场的一些主要参与者包括:
- Glaukos Corporation(美国)
- Ivantis Inc.(美国)
- AbbVie Inc.(美国)
- Ellex (美国)
- 爱尔康(瑞士)
- 英属维尔京群岛(美国)
- 强生外科视力保健公司 (美国)
- 显微外科技术(美国)
- Molteno Ophthalmic Ltd. (新西兰)
- New world Medical Inc.(美国)
- 参天制药株式会社(日本)
- Sight Scientific(美国)
- 博士伦公司。(加拿大)
- NeoMedix Healthcare India Pvt. Ltd.(美国)
- IOPtima(以色列)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.